A Road Map for Designing Phase I Clinical Trials of Radiotherapy–Novel Agent Combinations

Radiotherapy has proven efficacy in a wide range of cancers. There is growing interest in evaluating radiotherapy–novel agent combinations and a drive to initiate this earlier in the clinical development of the novel agent, where the scientific rationale and preclinical evidence for a radiotherapy c...

Descripción completa

Detalles Bibliográficos
Autores principales: Brown, Sarah R., Hinsley, Samantha, Hall, Emma, Hurt, Chris, Baird, Richard D., Forster, Martin, Scarsbrook, Andrew F., Adams, Richard A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2022
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9433953/
https://www.ncbi.nlm.nih.gov/pubmed/35552622
http://dx.doi.org/10.1158/1078-0432.CCR-21-4087

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9433953/
https://www.ncbi.nlm.nih.gov/pubmed/35552622
http://dx.doi.org/10.1158/1078-0432.CCR-21-4087

Ejemplares similares